Company Overview of Tekla Life Sciences Investors
Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as market position for services or products, experience of b...
2 Liberty Square
Boston, MA 02109
Founded in 1992
Key Executives for Tekla Life Sciences Investors
Principal Executive Officer, President, Trustee and Member of Valuation Committee
Principal Financial Officer, Chief Compliance Officer, Secretary and Treasurer
Compensation as of Fiscal Year 2015.
Tekla Life Sciences Investors Key Developments
Tekla Life Sciences Investors Declares Special Cash Distribution, Payable on January 8, 2016
Dec 18 15
On December 18, 2015, Tekla Life Sciences Investors declared a special cash distribution of $0.71 per share in order to satisfy annual tax distribution requirements. The record date for the distribution is December 30, 2015 and the payable date is January 8, 2016. The Fund will trade ex-distribution on December 28, 2015.
Tekla Life Sciences Investors Declares Stock Distribution, Payable on June 30, 2015
May 15 15
On May 15, 2015, Tekla Life Sciences Investors declared a stock distribution of $0.54 per share. The record date for the stock distribution is May 27, 2015 and the payable date is June 30, 2015. The Fund will trade ex-distribution on May 22, 2015.
Tekla Life Sciences Investors, Annual General Meeting, Jun 04, 2015
Apr 20 15
Tekla Life Sciences Investors, Annual General Meeting, Jun 04, 2015., at 08:30 US Eastern Standard Time. Location: Downtown Harvard Club of Boston. Agenda: To propose the election of trustees of fund; to consider the ratification or rejection of the selection of Deloitte & Touche LLP as the independent registered public accountants of fund for the fiscal year ending September 30, 2015; and to consider the transaction of such other business as may properly come before the annual meeting and any adjournment(s) or postponement(s) thereof.
Similar Private Companies By Industry
Recent Private Companies Transactions